Stephanie M. Bates

637 total citations
8 papers, 440 citations indexed

About

Stephanie M. Bates is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Stephanie M. Bates has authored 8 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Genetics. Recurrent topics in Stephanie M. Bates's work include RNA Interference and Gene Delivery (3 papers), Virus-based gene therapy research (2 papers) and COVID-19 and Mental Health (1 paper). Stephanie M. Bates is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), Virus-based gene therapy research (2 papers) and COVID-19 and Mental Health (1 paper). Stephanie M. Bates collaborates with scholars based in United Kingdom, Sweden and South Korea. Stephanie M. Bates's co-authors include Maelle Mairesse, Catherine J. Betts, Lauren A. Callender, Edward J. Sayers, Arwyn T. Jones, Arpan S. Desai, S Peel, Sanyogitta Puri, Marianne Ashford and R. England and has published in prestigious journals such as ACS Nano, Journal of Controlled Release and Nanoscale.

In The Last Decade

Stephanie M. Bates

5 papers receiving 436 citations

Peers

Stephanie M. Bates

MB

ID

CR

IMMUN

NEURO

Jingliang Chen China

Zezhou Zhao United States

Shaofang Xie China

Julio Sainz de Aja Spain

Jiansheng Liu China

Bridget Sanford United States

Yue Yin China

Rabeb Mouna Derbali Canada

Xixiong Kang China

Jingliang Chen China

Stephanie M. Bates

197 ×0.8

MB

56 ×0.5

ID

78 ×1.0

CR

68 ×1.4

IMMUN

21 ×0.4

NEURO

Citations per year, relative to Stephanie M. Bates Stephanie M. Bates (= 1×) peers Jingliang Chen

Countries citing papers authored by Stephanie M. Bates

Since Specialization

Citations

This map shows the geographic impact of Stephanie M. Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie M. Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie M. Bates more than expected).

Fields of papers citing papers by Stephanie M. Bates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie M. Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie M. Bates. The network helps show where Stephanie M. Bates may publish in the future.

Co-authorship network of co-authors of Stephanie M. Bates

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie M. Bates. A scholar is included among the top collaborators of Stephanie M. Bates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie M. Bates. Stephanie M. Bates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bates, Stephanie M., Michael J. Munson, Vítor Trovisco, et al.. (2025). The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity. Journal of Controlled Release. 386. 114047–114047.

2.

Hutchinson, James C., R. D. Shannon, Aditya Murthy, et al.. (2025). Physicochemical and functional assessment of messenger RNA 5′Cap-end impurities under forced degradation conditions. Molecular Therapy — Nucleic Acids. 36(2). 102570–102570.

3.

Bates, Stephanie M., et al.. (2024). Immune safety challenges facing the preclinical assessment and clinical progression of cell therapies. Drug Discovery Today. 29(12). 104239–104239.

4.

Bates, Stephanie M., et al.. (2021). Controlled Pulmonary Delivery of Carrier-Free Budesonide Dry Powder by Atomic Layer Deposition. ACS Nano. 15(4). 6684–6698. 41 indexed citations

5.

Callender, Lauren A., et al.. (2020). The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. Frontiers in Immunology. 11. 1991–1991. 132 indexed citations

6.

Saleh, Amer F., Elisa Lázaro‐Ibáñez, Olga Shatnyeva, et al.. (2019). Extracellular vesicles induce minimal hepatotoxicity and immunogenicity. Nanoscale. 11(14). 6990–7001. 144 indexed citations

7.

Sayers, Edward J., S Peel, R. England, et al.. (2019). Endocytic Profiling of Cancer Cell Models Reveals Critical Factors Influencing LNP-Mediated mRNA Delivery and Protein Expression. Molecular Therapy. 27(11). 1950–1962. 90 indexed citations

8.

Lamore, Sarah D., Ernst Ahlberg, Scott Boyer, et al.. (2017). Deconvoluting Kinase Inhibitor Induced Cardiotoxicity. Toxicological Sciences. 158(1). 213–226. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact